The impact of metastatic sites on checkpoint inhibitor outcomes in patients with cutaneous and unknown primary melanoma Meeting Abstract


Authors: Krieger, P.; Sanchez-Vega, F.; Schultz, N.; Shoushtari, A.
Abstract Title: The impact of metastatic sites on checkpoint inhibitor outcomes in patients with cutaneous and unknown primary melanoma
Meeting Title: 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 7
Issue: Suppl. 1
Meeting Dates: 2019 Nov 6-10
Meeting Location: National Harbor, MD
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2019-11-01
Start Page: 282
Language: English
ACCESSION: WOS:000496473200717
PROVIDER: wos
PMCID: PMC6833189
PUBMED: 31694725
DOI: 10.1186/s40425-019-0763-1
Notes: Meeting Abstract: P295 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nikolaus D Schultz
    488 Schultz